Relay Therapeutics 

Relay Therapeutics 

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$0
$350
$3,000
$7,000
Gross Profit
350
2,496
6,401
EBITDA
-81,465
-83,347
-72,787
-54,291
EBIT
-81,745
-83,707
-73,291
-54,890
Net Income
-81,745
-83,707
-73,291
-54,890
Net Change In Cash
0
350
3,000
7,000
Free Cash Flow
-63,934
-54,109
-51,112
-44,866
Cash
124,184
121,189
204,589
84,018
Basic Shares
219,157
202,849
179,849
171,586

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$15,355
$10,007
$25,546
$1,381
Gross Profit
11,798
-305,434
-300,841
-241,624
EBITDA
-272,922
-380,210
-374,153
-306,822
EBIT
-276,479
-385,674
-379,422
-310,952
Net Income
-276,479
-337,708
-341,973
-290,509
Net Change In Cash
15,355
10,007
25,546
1,381
Cost of Revenue
-128,325
Free Cash Flow
-235,865
-251,125
-304,442
-238,552
Cash
84,018
124,287
143,736
151,794
Basic Shares
171,586
142,867
122,576
112,233

Earnings Calls

QuarterEPS
2026-09-30
-$0.37
2026-06-30
-$0.41
2026-03-31
-$0.41
2025-12-31
-$0.32